Cetuximab Therapy in Head and Neck Cancer: Immune Modulation with Interleukin-12 and Other Natural Killer Cell Activating Cytokines

Por Luedke, Eric, Jaime-Ramirez, Alena Cristina, Bhave, Neela, Roda, Julie, Carson, William E.
Publicado em 2012

Hypoxia Inducible Factors-Mediated Inhibition of Cancer by GM-CSF: A Mathematical Model

Por Chen, Duan, Roda, Julie M., Marsh, Clay B., Eubank, Timothy D., Friedman, Avner
Publicado em 2012

Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes

Por Eubank, Tim D., Roda, Julie M., Liu, Haowen, O'Neil, Todd, Marsh, Clay B.
Publicado em 2011

HIF-2α regulates GM-CSF-derived sVEGFR-1 production from macrophages and inhibits tumor growth and angiogenesis

Por Roda, Julie M., Sumner, Laura A., Evans, Randall, Phillips, Gary S., Marsh, Clay B., Eubank, Timothy D.
Publicado em 2011

Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model()

Por Roda, Julie M., Wang, Yijie, Sumner, Laura A., Phillips, Gary S., Marsh, Clay B., Eubank, Timothy D.
Publicado em 2012

Colocalization of the IL-12 receptor and FcγRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-γ

Por Kondadasula, Sri Vidya, Roda, Julie M., Parihar, Robin, Yu, Jianhua, Lehman, Amy, Caligiuri, Michael A., Tridandapani, Susheela, Burry, Richard W., Carson, William E.
Publicado em 2008

A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab

Por Mani, Aruna, Roda, Julie, Young, Donn, Caligiuri, Michael A., Fleming, Gini F., Kaufman, Peter, Brufsky, Adam, Ottman, Susan, Carson, William E., Shapiro, Charles L.
Publicado em 2008

FcγR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways

Por Ganesan, Latha P., Joshi, Trupti, Fang, Huiqing, Kutala, Vijay Kumar, Roda, Julie, Trotta, Rossana, Lehman, Amy, Kuppusamy, Periannan, Byrd, John C., Carson, William E., Caligiuri, Michael A., Tridandapani, Susheela
Publicado em 2006

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

Por Bekaii-Saab, Tanios S., Roda, Julie M., Guenterberg, Kristan D., Ramaswamy, Bhuvanaswari, Young, Donn C., Ferketich, Amy K., Lamb, Tammy A., Grever, Michael R., Shapiro, Charles L., Carson, William E.
Publicado em 2009

Fcγ Receptor-induced Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Production Inhibits Angiogenesis and Enhances Efficacy of Anti-tumor Antibodies

Por Justiniano, Steven E., Elavazhagan, Saranya, Fatehchand, Kavin, Shah, Prexy, Mehta, Payal, Roda, Julie M., Mo, Xiaokui, Cheney, Carolyn, Hertlein, Erin, Eubank, Timothy D., Marsh, Clay, Muthusamy, Natarajan, Butchar, Jonathan P., Byrd, John C., Tridandapani, Susheela
Publicado em 2013

IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leu...

Por Gowda, Aruna, Roda, Julie, Hussain, Syed-Rehan A., Ramanunni, Asha, Joshi, Trupti, Schmidt, Susan, Zhang, Xiaoli, Lehman, Amy, Jarjoura, David, Carson, William E., Kindsvogel, Wayne, Cheney, Carolyn, Caligiuri, Michael A., Tridandapani, Susheela, Muthusamy, Natarajan, Byrd, John C.
Publicado em 2008

CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody

Por Awan, Farrukh T., Lapalombella, Rosa, Trotta, Rossana, Butchar, Jonathan P., Yu, Bo, Benson, Don M., Roda, Julie M., Cheney, Carolyn, Mo, Xiaokui, Lehman, Amy, Jones, Jeffrey, Flynn, Joseph, Jarjoura, David, Desjarlais, John R., Tridandapani, Susheela, Caligiuri, Michael A., Muthusamy, Natarajan, Byrd, John C.
Publicado em 2010

IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production

Por Jaime-Ramirez, Alena Cristina, Mundy-Bosse, Bethany L., Kondadasula, SriVidya, Jones, Natalie B., Roda, Julie M., Mani, Aruna, Parihar, Robin, Karpa, Volodymyr, Papenfuss, Tracey L., LaPerle, Krista M., Biller, Elizabeth, Lehman, Amy, Chaudhury, Abhik Ray, Jarjoura, David, Burry, Richard W., Carson, William E.
Publicado em 2011

NK Cell–Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin are Enhanced by Cytokines

Por Jaime-Ramirez, Alena C., McMichael, Elizabeth, Kondadasula, SriVidya, Skinner, Cassandra C., Mundy-Bosse, Bethany L., Luedke, Eric, Jones, Natalie B., Mani, Aruna, Roda, Julie, Karpa, Volodymyr, Li, Hong, Li, Jilong, Elavazhagan, Saranya, La Perle, Krista M., Schmitt, Alessandra C., Lu, Yanhui, Zhang, Xiaoli, Pan, Xueliang, Mao, Hsaioyin, Davis, Melanie, Jarjoura, David, Butchar, Jonathan P., Poi, Ming, Phelps, Mitch, Tridandapani, Susheela, Byrd, John C., Caligiuri, Michael A., Lee, Robert J., Carson, William E.
Publicado no Cancer Immunol Res (2016)